Factor This Power Engineering
Live Events
DTECH® Events
POWERGEN™
INFOCAST Events
Calendar
Webinars
Podcasts
Factor This
This Week in Cleantech
Factor This Policycast
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
POWERGEN™
INFOCAST Events
Podcasts
Factor This
Factor This Policycast
This Week in Cleantech
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Aura Biosciences, Inc. - Common Stock
(NQ:
AURA
)
6.840
-0.160 (-2.29%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Aura Biosciences, Inc. - Common Stock
< Previous
1
2
3
Next >
Aura Biosciences Gears Up for Bel-Sar Filing as Pivotal Eye Cancer Trial Advances
↗
May 27, 2026
Aura Biosciences (NASDAQ:AURA) is shifting its focus toward regulatory preparation and commercialization planning as enrollment in its registrational CoMpass study of bel-sar in early choroidal...
Via
MarketBeat
Aura Biosciences Highlights Bel-Sar Eye Cancer Strategy, Mid-Year Bladder Data
↗
May 19, 2026
Aura Biosciences (NASDAQ:AURA) executives outlined the company’s strategy for its lead candidate bel-sar during a session at the H.C. Wainwright Connect Conference, emphasizing ocular oncology as the...
Via
MarketBeat
BETA Technologies, Starfighters Space And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
March 09, 2026
U.S. stock futures lower, with Dow futures down over 1%. BETA Technologies (NYSE: BETA) fell in pre-market trading after reporting fourth-quarter results. Other stocks declining in pre-market trading...
Via
Benzinga
Topics
Stocks
Recap: Aura Biosciences Q4 Earnings
↗
March 27, 2024
Via
Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
↗
January 06, 2026
Via
Chartmill
Aura Biosciences Posts Q2 Cash Surge
↗
August 13, 2025
Via
The Motley Fool
Topics
Intellectual Property
4 Artificial Intelligence Stocks (That Aren't Nvidia) You Can Buy and Hold for the Next Decade
↗
July 29, 2025
These AI companies offer long-term growth potential and are worth holding for years to come.
Via
The Motley Fool
Topics
Artificial Intelligence
Why United Airlines Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
↗
April 16, 2025
Via
Benzinga
US Stocks Likely To Open Mixed: 'Expect Volatility. Buckle Up,' Says Expert
↗
March 27, 2025
U.S. stock futures were swinging between gains and losses on Thursday after snapping a three-day winning streak on Wednesday. Futures of major benchmark indices were mixed in premarket trading. Aiming...
Via
Benzinga
Topics
Supply Chain
World Trade
Why Greenland Technologies Shares Are Trading Higher By Around 89%; Here Are 20 Stocks Moving Premarket
↗
March 27, 2025
Via
Benzinga
Why Check-Cap Shares Are Trading Higher By Over 52%; Here Are 20 Stocks Moving Premarket
↗
January 03, 2025
Via
Benzinga
Aura Biosciences' Bladder Cancer Candidate Demonstrates Tumor Shrinkage In Patients With High-Grade Disease
↗
October 18, 2024
Aura Biosciences released early Phase 1 trial data on bel-sar for non-muscle-invasive bladder cancer, showing promising clinical activity and a favorable safety profile.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
October 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
October 14, 2024
Via
Benzinga
Aura Biosciences Touts Promising Data From Eye Cancer Candidate
↗
September 12, 2024
Aura Biosciences announced promising Phase 2 results for bel-sar in treating melanoma, achieving 80% tumor control.
Via
Benzinga
AURA Stock Earnings: Aura Biosciences Beats EPS for Q2 2024
↗
August 08, 2024
AURA stock results show that Aura Biosciences beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
AURA Stock Earnings: Aura Biosciences Beats EPS for Q1 2024
↗
May 09, 2024
AURA stock results show that Aura Biosciences beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
AURA Stock Earnings: Aura Biosciences Beats EPS for Q4 2023
↗
March 27, 2024
AURA stock results show that Aura Biosciences beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
January 09, 2024
Via
Benzinga
Over $13M Bet On This Energy Stock? Check Out These 4 Stocks Insiders Are Buying
↗
November 10, 2023
Although U.S. stocks closed lower on Thursday, there were a few notable insider trades.
Via
Benzinga
Why Aura Biosciences Stock Hit A New 52-Week Low Today
↗
November 07, 2023
Aura Biosciences Inc (NASDAQ: AURA) shares are trading lower by 34.7% to $7.18 Tuesday afternoon after the company announced pricing of its public offering of common st
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
November 07, 2023
Via
Benzinga
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
November 07, 2023
Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry.
Via
Benzinga
Why Alteryx Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
↗
November 07, 2023
Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares surged 120.8% to $0.6450 in pre-market trading after the company reported a new strategic collaboration with Celest Therapeutics for the clinical...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
November 07, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
November 07, 2023
It's time for another dive into the biggest pre-market stock movers as we break down all of the latest news for Tuesday morning.
Via
InvestorPlace
Sanmina, Adtran, Ameresco And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
November 07, 2023
U.S. stock futures traded lower this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
November 06, 2023
Via
Benzinga
Top 5 Health Care Stocks That May Fall Off A Cliff This Month
↗
November 06, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023
↗
July 27, 2023
Via
Benzinga
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
